Impaired hemostasis and protection against thrombosis in protease‐activated receptor 4‐deficient mice is due to lack of thrombin signaling in platelets
- 10 August 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (8), 1429-1435
- https://doi.org/10.1111/j.1538-7836.2004.00783.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cellsBlood, 2003
- Protection against thrombosis in mice lacking PAR3Blood, 2002
- Role of thrombin signalling in platelets in haemostasis and thrombosisNature, 2001
- PAR3 is a cofactor for PAR4 activation by thrombinNature, 2000
- A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosisProceedings of the National Academy of Sciences, 1998
- A dual thrombin receptor system for platelet activationNature, 1998
- Antibodies to Protease-Activated Receptor 3 Inhibit Activation of Mouse Platelets by ThrombinBlood, 1998
- Role of the thrombin receptor in development and evidence for a second receptorNature, 1996
- Susceptibility to Infection and Altered Hematopoiesis in Mice Deficient in Both P- and E-SelectinsCell, 1996
- Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte developmentCell, 1995